Expression and purification of SenX3 from the Mycobacterium tuberculosis strain H37Rv in Escherichia coli
- Authors:
- Huoyang Lv
- Liqing Hu
- Qingfeng Hu
- Quhao Wei
- Peiqiong Shen
View Affiliations
Affiliations: Center of Laboratory Medicine, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China, Department of Laboratory Medicine, The First Ningbo Hospital, Ningbo, Zhejiang 315000, P.R. China
- Published online on: April 26, 2013 https://doi.org/10.3892/mmr.2013.1449
-
Pages:
1960-1964
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Infection with the bacterium Mycobacterium tuberculosis (MTB) causes tuberculosis, a pulmonary infection that may be fatal if left untreated. Misuse or mismanagement of tuberculosis drugs may lead to drug-resistant pathogen forms that are difficult to treat and contribute to a global health problem. The MTB SenX3/RegX3 signal transduction system allows bacteria to externally sense the environment and mediate an appropriate internal response; SenX3 is also associated with MTB virulence, suggesting that this protein may provide a potential therapeutic target. To investigate the role of SenX3 and MTB drug resistance, SenX3 was cloned, expressed and purified in Escherichia coli. SenX3 was cloned from the genome of the MTB strain H37Rv by polymerase chain reaction and an internal NcoI restriction site was destroyed by site-directed mutagenesis to allow cloning into the pET-28b prokaryotic expression vector. SenX3 expression from the resulting pET‑28b-mSenX3 plasmid was induced with isopropyl β-D-thiogalactoside and the protein was purified using Ni-NTA agarose affinity chromatography. A pure protein of the expected size was identified. The examination of purified SenX3 protein is considered to enable the in‑depth investigation of SenX3-mediated drug resistance.
View Figures |
Figure 1
|
 |
Figure 2
|
 |
Figure 3
|
 |
Figure 4
|
 |
Figure 5
|
 |
Figure 6
|
 |
Figure 7
|
View References
|
1
|
Maxmen A: TB drugs chalk up rare win.
Nature. 487:413–414. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
World Health Organization. Multidrug and
extensively drug-resistant TB (M/XDR-TB): 2010 global report on
surveillance and response. World Health Organization; Geneva,
Switzerland: 2010
|
|
3
|
Crunkhorn S: Trial watch: Novel
antimicrobial fights TB resistance. Nat Rev Drug Discov.
11:5902012. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kalokhe AS, Shafiq M, Lee JC, Ray SM, Wang
YF, Metchock B, Anderson AM and Nguyen ML: Multidrug-resistant
tuberculosis drug susceptibility and molecular diagnostic testing.
Am J Med Sci. 345:143–148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bretl DJ, Demetriadou C and Zahrt TC:
Adaptation to environmental stimuli within the host: two-component
signal transduction systems of Mycobacterium tuberculosis.
Microbiol Mol Biol Rev. 75:566–582. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cole ST, Brosch R, Parkhill J, et al:
Deciphering the biology of Mycobacterium tuberculosis from
the complete genome sequence. Nature. 393:537–544. 1998.
|
|
7
|
Parish T, Smith DA, Roberts G, Betts J and
Stoker NG: The senX3-regX3 two-component regulatory system of
Mycobacterium tuberculosis is required for virulence.
Microbiology. 149:1423–1435. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rickman L, Saldanha JW, Hunt DM, et al: A
two-component signal transduction system with a PAS
domain-containing sensor is required for virulence of
Mycobacterium tuberculosis in mice. Biochem Biophys Res
Commun. 314:259–267. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rifat D, Bishai WR and Karakousis PC:
Phosphate depletion: a novel trigger for Mycobacterium
tuberculosis persistence. J Infect Dis. 200:1126–1135. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
An Y, Ji J, Wu W, Lv A, Huang R and Wei Y:
A rapid and efficient method for multiple-site mutagenesis with a
modified overlap extension PCR. Appl Microbiol Biotechnol.
68:774–778. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Green MR and Sambrook J: Molecular
Cloning: A Laboratory Manual. 4th edition. Cold Spring Harbor
Laboratory Press; Cold Spring Harbor, New York: 2012
|
|
12
|
Carroll P, Faray-Kele MC and Parish T:
Identifying vulnerable pathways in Mycobacterium
tuberculosis by using a knockdown approach. Appl Environ
Microbiol. 77:5040–5043. 2011.PubMed/NCBI
|
|
13
|
Himpens S, Locht C and Supply P: Molecular
characterization of the mycobacterial SenX3-RegX3 two-component
system: evidence for autoregulation. Microbiology. 146:3091–3098.
2000.PubMed/NCBI
|
